TSX open
Loading markets…

Advertisement

Stocks/TSX/CSCI

COSCIENS Biopharma Inc. (CSCI : TSX)

Common Stock

$7.10

CAD

-0.05 (-0.70%)

Last updated: 2026-07-31

Get CSCI alerts:

CSCI

COSCIENS Biopharma Inc.

Source:WealthAwesomeWealthAwesome
$4.09 (135.88%)
30 day period
$2.80$7.87$12.94Jun 19Jul 13Jul 31

Performance

1 Day

+0.00%

1 Week

-7.79%

1 Month

+93.99%

YTD

+144.83%

Key Statistics

Market Cap

$7.07M

52W High

$14.80

52W Low

$1.10

P/E Ratio

-

50 Day MA

$18.68

200 Day MA

$23.15

Beta

1.90

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/31/2026$7.10$7.10$7.08$7.10$7.10700
7/30/2026$7.11$7.15$7.10$7.15$7.15419
7/29/2026$7.56$7.90$7.00$7.90$7.903,434
7/28/2026$7.90$7.90$7.90$7.90$7.90261
7/27/2026$7.70$7.70$7.70$7.70$7.700
7/24/2026$7.85$7.85$7.70$7.70$7.70414
7/23/2026$7.75$7.75$7.75$7.75$7.751,141
7/22/2026$7.56$7.62$7.52$7.62$7.621,204
7/21/2026$7.76$7.76$7.56$7.75$7.751,000
7/20/2026$7.90$7.90$7.55$7.55$7.552,791

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CSCI's historical volatility

HistoricalForecast68%95%
C$0.01C$1688.30C$3376.59C$5064.88C$6753.17C$8441.46TodayMar 25May 29Jul 31Sep 12Oct 26Dec 8

30-Day Vol

575.0%

Annualized

90-Day Vol

353.9%

Annualized

Trend (90d)

+50.0%

Annualized drift

90d Mean

C$8.49

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$7.54C$1.04C$54.79
60 trading daysC$8.00C$0.48C$132.28
90 trading daysC$8.49C$0.27C$263.75

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About COSCIENS Biopharma Inc.

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important biologically active components; and avenanthramides, a natural-based ingredients used to inflammation-based diseases for the cosmeceutical and pharmaceutical industries. It also provides Macrilen/Ghryvelin (macimorelin), an orally active peptidomimetic small molecule that stimulates the secretion of growth hormone from the pituitary gland. The company sells its products through its distribution network. It has license agreements with Pharmanovia, Davimed GmbH, and NK MEDITECH Ltd, as well as Agriculture Canada, Canadian Government, and University of Alberta. The company was formerly known as Aeterna Zentaris Inc. and changed its name to COSCIENS Biopharma Inc. in August 2024. COSCIENS Biopharma Inc. was incorporated in 1990 and is based in Toronto, Canada.

Financials

Revenue (TTM)
$8.00M
EBITDA
$-7.57M
Profit Margin
50.68%
ROE (TTM)
-61.79%
EPS (Diluted)
-10.44
Book Value
20.26

🔄 Recent Splits

50-for-150

Jul 3, 2026

Reverse

1-for-4

May 3, 2024

Reverse

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About CSCI

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ADCOAdcore Inc$0.14+0.00%
APLIAppili Therapeutics Inc$0.01+0.00%
ASCUArizona Sonoran Copper Company Inc$8.06+0.00%
ATCUAlta Copper Corp.$1.39+0.00%
AX-UNArtis Real Estate Investment Trust$25.61+0.00%
BBU-UNBrookfield Business Partners L.P.$45.79+0.00%
BITFBitfarms Ltd$8.24+0.00%
BNGBengal Energy Ltd$0.02+0.00%

CSCI.TO news timeline

15 articles covering CSCI.TO, most recent first

Latest

Why COSCIENS Biopharma Inc. stock is skyrocketing today

Stocks

Advertisement